Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$242.49 - $301.46 $7,517 - $9,345
-31 Reduced 2.91%
1,036 $254,000
Q2 2022

Aug 08, 2022

BUY
$224.73 - $338.64 $15,056 - $22,688
67 Added 6.7%
1,067 $264,000
Q1 2022

May 10, 2022

BUY
$277.25 - $366.29 $277,250 - $366,290
1,000 New
1,000 $331,000
Q4 2021

Feb 11, 2022

SELL
$300.63 - $371.35 $30,363 - $37,506
-101 Closed
0 $0
Q3 2021

Nov 08, 2021

SELL
$310.19 - $376.2 $10,856 - $13,167
-35 Reduced 25.74%
101 $33,000
Q2 2021

Aug 09, 2021

BUY
$262.71 - $351.17 $262 - $351
1 Added 0.74%
136 $42,000
Q1 2021

Apr 28, 2021

SELL
$285.92 - $355.13 $101,787 - $126,426
-356 Reduced 72.51%
135 $43,000
Q4 2020

Feb 09, 2021

SELL
$251.88 - $324.2 $535,496 - $689,249
-2,126 Reduced 81.24%
491 $159,000
Q3 2020

Nov 02, 2020

BUY
$255.22 - $317.0 $9,187 - $11,412
36 Added 1.39%
2,617 $725,000
Q2 2020

Aug 11, 2020

SELL
$141.4 - $257.09 $55,428 - $100,779
-392 Reduced 13.19%
2,581 $624,000
Q1 2020

May 15, 2020

BUY
$130.51 - $196.01 $302,000 - $453,567
2,314 Added 351.14%
2,973 $432,000
Q4 2019

Feb 13, 2020

BUY
$159.31 - $223.54 $104,666 - $146,865
657 Added 32850.0%
659 $113,000
Q3 2019

Oct 17, 2019

SELL
$175.89 - $279.23 $43,444 - $68,969
-247 Reduced 99.2%
2 $0
Q2 2019

Aug 05, 2019

BUY
$250.96 - $284.94 $8,532 - $9,687
34 Added 15.81%
249 $65,000
Q1 2019

Apr 16, 2019

SELL
$276.39 - $362.25 $867,035 - $1.14 Million
-3,137 Reduced 93.59%
215 $61,000
Q3 2018

Nov 02, 2018

BUY
$354.53 - $449.75 $169,465 - $214,980
478 Added 16.63%
3,352 $0
Q2 2018

Jul 24, 2018

BUY
$278.07 - $446.21 $429,618 - $689,394
1,545 Added 116.25%
2,874 $0
Q1 2018

May 03, 2018

BUY
$192.49 - $295.85 $1,924 - $2,958
10 Added 0.76%
1,329 $387,000
Q4 2017

Feb 02, 2018

BUY
$168.78 - $199.74 $219,076 - $259,262
1,298 Added 6180.95%
1,319 $246,000
Q3 2017

Oct 20, 2017

BUY
$145.39 - $168.6 $3,053 - $3,540
21
21 $4,000

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.